Syngene International Q4FY24 Business Update: The business finds it hard to grow. Sales de-grew 8% YOY in Q4 and the management expects growth in single-digits YOY in FY25. Syngene is a great business model but none of that greatness matters if the business cannot grow sales at a fast pace. Shareholders shall remain stuck in the stock till growth comes back in play.
@shome_rajarshi #syngene, Well so called @GoldmanSachs, #Goldmansachs came out with a report giving target of 875. Amazing research to fool investors just before the results.
@shome_rajarshi @GoldmanSachs @GoldmanSachs ,#Sygnene. Am surprised by Goldman sachs recommendation nowdays. Post results the target for Syngene is still 835 odd and look where its standing. Prob say very poor research